Skip to main content

‘Significant progress’ for life sciences business Optibiotix

‘Significant progress’ for life sciences business Optibiotix

Optibiotix says it has made “significant progress” developing a pipeline of innovative products in the first half of the year as it evolves from a technology company to a product firm, following the flotation of its skincare-focused subsidiary and investment in a weight loss business.

Stephen O’Hara, CEO of OptiBiotix, said: “OptiBiotix has made significant progress in the last six months developing a pipeline of innovative products with a strong scientific and clinical evidence base.”

See the article in full at TheBusinessDesk.com

Contact Us

Online form

If you would like to speak to us about an investment opportunity or would like some information on how to invest with Seneca, please contact us and a member of the team will be pleased to help you.
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.
Visit Seneca Partners Website